72F fusion protein vaccine is a candidate
tuberculosis vaccine
Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch.Prabowo, S. et al. "Targeting multidrug-resistant tuberculosis (MDR-TB) by ...
created by
Statens Serum Institut (SSI). The 72F fusion protein is composed of the
Rv0125 and
Rv1196 proteins derived from ''
Mycobacterium tuberculosis''.
Phase I clinical trials were completed in 2005 and Phase II trials are awaited.
See also
*
Fusion protein
References
*
Tuberculosis vaccines
Protein subunit vaccines
{{immunology-stub